Overview
- Description
The company is pioneering exosome-based regenerative therapies, developing a patented platform to produce extracellular vesicles for healing digestive tissues and regenerating organs like the liver and kidney, with plans to commercialise through pharma partnerships.
- Website
- Country
- France
- Sector
- Health Biotechnology
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.